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Abstract
Aristolochia longa L. is a plant native to Algeria and Morocco that has been used by the locals to combat
different arrays of infections and diseases found among them. This particular plant is well-known for its
therapeutic qualities that could be traced back to the presence of many effective phytochemicals that
have been extrapolated from the different parts of the plant, like the leaves and roots: flavonoids,
saponins, tannins, 4-hydroxybenzoic acid, β-carotenes, limonenes, and palmitic acids. This plant has been
identified in different research articles to be able to manage diseases effectively because it possesses
some pharmacological attributes such as; antitumor/anti-inflammatory, anti-cancer, anti-diabetic, antimicrobial, anti-fungal, as well as antioxidant properties. This review covers the ethnobotanical,
phytochemical, and pharmacological activities of A. longa as well as its toxicological aspects. A thorough
review of scientific literature published in a number of databases, including Scopus, Web of Science, and
PubMed, was used to acquire relevant data for A. longa. The plant includes phytochemicals that have
been proven to alleviate a variety of diseases. As a result, it's safe to claim that this plant is a good source
of traditional medicine, which could be useful in medication development, bearing in mind that it could
also be toxic depending on its consumption rate locally.
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Abstract
Aristolochia longa L. is a plant native to Algeria and Morocco that has been used by the locals to combat different
arrays of infections and diseases found among them. This particular plant is well-known for its therapeutic qualities that
could be traced back to the presence of many effective phytochemicals that have been extrapolated from the different
parts of the plant, like the leaves and roots: ﬂavonoids, saponins, tannins, 4-hydroxybenzoic acid, b-carotenes, limonenes, and palmitic acids. This plant has been identiﬁed in different research articles to be able to manage diseases
effectively because it possesses some pharmacological attributes such as; antitumor/anti-inﬂammatory, anti-cancer, antidiabetic, anti-microbial, anti-fungal, as well as antioxidant properties. This review covers the ethnobotanical, phytochemical, and pharmacological activities of A. longa as well as its toxicological aspects. A thorough review of scientiﬁc
literature published in a number of databases, including Scopus, Web of Science, and PubMed, was used to acquire
relevant data for A. longa. The plant includes phytochemicals that have been proven to alleviate a variety of diseases. As
a result, it's safe to claim that this plant is a good source of traditional medicine, which could be useful in medication
development, bearing in mind that it could also be toxic depending on its consumption rate locally.
Keywords: Aristolochia longa L, Ethnobotanical, Medicinal plant, Pharmacological, Phytochemistry

1. Introduction

I

n recent years, the trend of using plants with
medicinal properties cannot be ignored, as they
have formed the basis for drug manufacturing and
development [1,2]. There has been a signiﬁcant increase in the recognition and open interest in orthodox treatments in third-world nations. With
contemporary medical research in demand, the
healthiest alternatives to existing synthetic pharmaceuticals with various unfavorable and healthhazardous consequences are medicinal plants,
which are moving from marginal utilization to
widespread use [1]. These locally-made pharmaceuticals are widely available in drug stores, grocery
stores, and shopping malls. In African countries and

in certain developed nations, about 80% of the
population relies on alternative medications to cure
ailments due to the ease with which they can be
obtained and, most likely, the low cost factor associated with them when compared to contemporary
drugs [3]. Many people in developing countries,
including but not limited to Asia and Africa, rely
heavily on traditional remedies to treat various illnesses and ailments [4,5]. The ability to obtain these
plants without stress and with little or no money has
been a major reason for their widespread use [4e6].
Several diseases have been treated and managed as
a result of the various combinations of compounds
and phytoconstituents (which are known to operate
synergistically) to produce a new array of compounds that will act as essential herbal extracts [5,6].
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Recently, there has been a push to use novel
components and treatments in food and drug
manufacture to replace the contemporary ones,
which have been proven to have side effects that
limit their use among individuals [7,8]. Free radicals
have been shown to be scavenged by the synergistic
ability of phytoconstituents found in plants used as
medications. According to [8], a good source of
compounds high in pure antioxidants effectively
treats a variety of disorders or diseases with minimal or no negative effects on the human system.
Plants and human beings have a shared relationship in traditional cultures, which is a study known as
ethnobotany. Since the beginning of human existence
as well as civilization, the use of medicinal plants has
been a necessity to fully perform daily activities [9].
Recently, ethnobotanical studies have proven to be an
important means of determining novel plants that are
good for medicines or revisiting previously discovered bioactive substances [10]. The ﬁrst step in the
quality assurance of indigenous medicine is to use
them for formulating new drugs from the archives of
previously studied plants. This usage is known as
ethnobotanical identiﬁcation, and the knowledge of
the identiﬁcation helps in the proper utilization of the
available biological resources. In other words, indigenous plant consumption has enormous potential
socioeconomic advantages [11].
Aristolochia is a plant that belongs to the Aristolochiaceae family. The native plant utilization technique is used in the treatment of ailments such as
inﬂammation, skin disorders, and purgatives. The
antibacterial activity has been taken into account in
the research that led to the extraction of the root
[12]. The Aristolochiaceae are magnoliids, which are
angiosperms that do not fall into the big groups of
monocots or eudicots. According to the Angiosperm
Phylogeny Group, the family Aristolochiaceae belongs to the order Piperales (Table 1). Based on
anecdotal evidence, Aristolochia plants (Aristolochiaceae) are known to be utilized in all parts of
the world for a variety of diseases [10]. The primary

goal of this review is to comprehensively access the
vast and common traditional uses of Aristolochia
species, as well as to investigate their phytochemistry and pharmacological activities. Based on ethnopharmacological data, Aristolochia species are
used medicinally in numerous parts of the world,
but they also pose some risks (from a public health
perspective). An organized review of the aristolochic
acids that are produced in its utilization is required
to determine a potential health risk. Aristolochia
species have been linked to nephropathy, mostly in
China and Europe. The review covers the utility of
tackling the sickness (nephropathy) across all parts
of the world [10]. There is signiﬁcant evidence
suggesting that this species of Aristolochia is wellknown as a traditional medicine frequently used in
India and Central America [10,12].
1.1. Botanical description
Fig. 1 depicts the spindle-like shape of the root,
which ranges in length from 5 cm to 3 cm and has a
thickness of 2 cm. It is grayish in color externally,
highly brittle, ﬂeshy, brownish-yellow in color (inside), bitter, and has an awful odor when fresh. The
taste of the plant's root is very bitter, and its leaves
are long and thin, with violet-colored ﬂowers [13].

2. Research methodology
As a keyword, the name of the plant, Aristolochia
longa L., was used. Data for this review on A. longa L.
was gathered from internationally recognized scientiﬁc databases via an electronic search (Wiley,
SciFinder, Google Scholar, Springer, Web of Science, Francis & Taylor, Elsevier, PubMed, and The
PlantList database). Furthermore, the medical books
and PhD and MSc theses associated with A. longa,
have been thoroughly examined and excerpts from
them have been added to this review.

Table 1. Scientiﬁc classiﬁcation of Aristolochia longa L.
SCIENTIFIC CLASSIFICATION
Kingdom:
Clade:
Clade:
Clade:
Order:
Family:
Genus:
Species:
Binomial name
Aristolochia longa L.

Plantae
Tracheophytes
Angiosperms
Magnoliids
Piperales
Aristolochiaceae
Aristolochia
A. longa
Fig. 1. A pictorial image of Aristolochia longa L.
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3. Ethnobotanical study
An ethnobotanical survey was conducted in the
northwest part of Algeria in a remote province
called Mascara Province. They have a Mediterranean climate in the province, with about 450 mm of
annual precipitation. There were approximately
826,334 people (both males and females) living there
at the time, accounting for 1.04% of the population.
Archives for information preservation were created
through one-on-one conversations as well as semistructured interviews [14]. A statistical report was
also created to detail the portions of the plant that
were most frequently used, and the results were as
follows: roots (89%), leaves (9%), and the utilization
of the complete plant (2%). Another study was
evaluated to examine how the plant is prepared and
used, and the results were as follows: mixing the
crushed roots with honey and taking it orally ranked
ﬁrst at about 63%, followed by the combination of
crushed roots with milk at 13%, which was also
taken orally, followed by mixing the crushed roots
with other known plants that have medicinal potential at 12%, and ﬁnally, by boiling parts of the
plant in water and taking it orally at 11%. Skin illnesses such as infections and rheumatism have
been treated by using the plant's paste, which is
made by pulverizing the plant with olive oil or water
and applying it to the skin's surface [15,16].
Another study was undertaken in the east of
Algeria, at a town called Setif, roughly 300 km from
Algiers. The study included one hundred (100) local
volunteers, including elderly people and traditional
healers, and some of the questions asked were
about plant parts that were utilized in the cure of
illnesses, ailments cured by the plants, how the
plants were prepared, and how they were used, and
all the responses gotten were carefully recorded. As
a result of research in several areas of Setif (East
Algeria), people conﬁrmed the proposed thought
that A. longa has been utilized in medicine for a
number of purposes. Based on the information
gathered and presented, it was discovered that only
50% of the group was able to identify the plant and
knew how to use and prepare it, while the other 50%
did not. A. longa has been used to cure a variety of
diseases and health problems [17].

4. Phytochemistry
According to a study, A. longa extracts contain a
wide range of phenolic constituents. However, citric
acid was found to be the major phytochemical present in the aqueous fraction extracts of the root.
When a different solvent (ethyl acetate) was utilized
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as a fraction, 4-hydroxybenzoic acid was the main
component of the compounds. Furthermore, the
inconsistency of phenolic constituents in the ethyl
acetate fraction extraction is linked to the extraction
solvents.
Some of the bioactive chemicals depicted in Fig. 2
have been found to be abundant in extracts of A.
longa, including b-carotene, limonene, tannin,
ﬂavonoid, citric acid, catechin, rutin, quercetin,
kaempferol, 4-hydroxybenzoic acid, chlorogenic
acid, gallic acid, quinic acid, pyrogallol, and palmitic
acid, and have been shown to have pharmacological
effects [18] as shown in Table 2 [12].

5. Pharmacological activities
5.1. Antioxidant activity
The ability of a substance to inhibit the oxidation
of other substances or even deactivate free radicals
indicates that it has antioxidant qualities. A study by
Attou et al. [19], examined the antioxidant activity of
ﬂavonoids and polyphenols isolated from A. longa,
demonstrated that the plant has the potential to
have a biological effect due to the presence of some
chemicals (bioactive constituents), for example, ﬂavonoids, polyphenols, and tannins (markers of
antioxidant activity) [19]. Many studies have been
conducted to evaluate the potential effect that the
extracts of this plant would have on DPPH [20],
ABTS [21], FRAP [22] scavenging activities as they
aid in the neutralization of generated ROS. A. longa's
ability to scavenge free radicals has been determined using various parts of the plant. The strongest inhibition of plant root extracts was observed in
a study conducted by Merouani & Belhattab [14].
The aerial part of the plant was also investigated,
and it was reported that methanol extracts demonstrated strong DPPH activity in a dose-dependent
manner [14]. [19,20] reported the antioxidant capacity, reducing power, and radical scavenging activity (DPPH) of the methanolic leaf extracts of A.
longa. According to [24,25], in research carried out,
lead acetate was employed to create reactive oxygen
species. But due to the existence of these compounds, they played a vital function in scavenging
the produced free radicals. The ability of plant extracts to neutralize free radicals is solely related to
the increasing levels of phenolic compounds (14.22
and 11.76 mg GAE/g, respectively). According to
another study, A. longa has a greater amount of
phenolic compounds to scavenge free radicals (such
as hydroxyl radicals (OH.), superoxide radicals
(O2.), and other ROS). The primary use of A. longa's
antioxidant ability is to reduce oxidative stress by
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Fig. 2. Some selected bioactive compounds identiﬁed from A. longa extract.

scavenging radicals, which are the main cause of
lipid peroxidation [26].
5.2. Antitumor/anti-inﬂammatory activity
According to [27], the study's data shows that
applying the plant extract at a saturation limit
dosage of 10% to the gingival topical, promotes inﬂammatory reactions to various oral cavity tissues
(e.g., tongue, lips) as well as lung tissues, and is not
limited to only the focused treated tissues. As a
result, there were strong peribronchiolar hyperplastic lymphoid follicles as well as inﬂammatory

interstitial polymorphic congestion and inﬁltration.
This plant's rhizome included two primary components, AA-I, and AA-, both of which had stimulatory
immunological activities [28]. An earlier in vivo
investigation revealed that the aqueous extract of A.
longa might induce an immune-stimulatory response
in mice by enhancing both the humoral and cellular
immune responses when supplied orally (through
the mouth) [26,27]. This reaction was observed as a
result of the plant's immunostimulant effect, which
allows it to express its pro-inﬂammatory property.
Patients with systemic immunologic indications of
tumors typically have suppression, which can be

O.A. Ojo et al. / Karbala International Journal of Modern Science 8 (2022) 375e382
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Table 2. Some phytochemical Constituents of Aristolochia longa extracts
[12].

5.3. Antidiabetic activity

S/N

Phenolic acids

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32

Quinic acid
Malic acid
Pyrogallol
Citric acid
Succinic acid
Gallic acid
Chlorogenic acid
3,4-Hydroxybenzoic acid
Pyrocatechol
4-Hydroxybenzoic acid
3-Hydroxybenzoic acid
Catechin
Caffeic acid
Epicatechin
Benzoic acid
Epigallocatechin gallate
Syringic acid
Vanillic acid
4-Hydroxycinnamic acid
Rutin
Sinapic acid
3-Hydroxycinnamic acid
Ferulic acid
Quercitin
2-Hydroxycinnamic acid
Salicylic acid
Naringin
Rosmarinic acid
Luteolin
Resveratrol acid
Quercitrin
Kaempferol

Several A. longa extracts have been tested for antidiabetic efﬁcacy [10]. This activity was assessed
using two separate in vitro assays, a-glucosidase,
and b-galactosidase uptake tests. Both enzymes
examined were inhibited by A. longa extracts. Their
ﬁndings are consistent with previous studies that
have found that two of its species, aerial portions of
Aristolochia indica [31] root extracts, reduced
increased blood glucose levels in animal models.
Inhibitory activities (a-glucosidase and b-glucosidase) have been examined via an in vitro analysis,
and it was found that the fraction (ethyl acetate)
shows the highest inhibitory effect [10,30].

measured as a reduction in the activity of the outer
layer of lymphocytes as well as a reduction in their
number [27]. These tumors play a role in mediating
suppression by secreting substances. But it is not the
only interaction between the host environment and
the increasing metastasizing tumor [27,29]. The
mystery of the anti-tumor [29,30] activity of A. longa
can be attributed to the extracts of the plant, which
induce the ability to combat tumor infections by
their immune-stimulating activity, followed by the
generation of inﬂammatory reactions and the
development of tissue necrosis through a high level
of cytotoxicity. A. longa revealed an increase in the
number of mononuclear cells when used to treat
experimental animals, as well as the lymphoid follicles and nodes that inﬁltrate the mononuclear
cells. It was also discovered that an expanding
number of different tissues containing eosinophils
were all investigated. Following AA activation, it
was explained by a series of pathways involving the
inﬂammatory reaction and its cytotoxicity, that the
NADPH oxidase catalyzes the reduction to superoxide from oxygen, releasing the ROS as quickacting mediators [27,29].

5.4. Antimicrobial/antifungal activity
The antifungal medications that are now being
manufactured are insufﬁcient because of the inhibition in drug selection as well as the side effects
that come with it, and the ability of pathogens
(fungals) to resist them [31]. The aqueous extract of
A. longa increases the level of inhibition of Saccharomyces cerevisiae cells. As a result, the plant is
classiﬁed as a medication that is effective in the
treatment of microbial infections [32]. E. coli, P. aeruginosa, S. faecalis, S. aureus, and S. epidermidis were
all re-strained by the plant's aristolochic acid [33].
Pathogenic bacteria present are acted on by metabolites produced by a series of biological reactions
contained in plant materials, and as a result, have
become a good source of therapy [34]. When plants
have medicinal potential, they ultimately have a
close relationship with their components [35]. The
plant of choice in this study, based on research, has
extremely good antifungal activity and this conclusion is drawn based on the compounds identiﬁed in
the A. longa aqueous extract [18].
5.5. Anticancer activity
An ethnobotanical study of A. longa revealed that
the herb has been utilized to treat cancer patients.
According to past studies, cancer therapy in Algeria
has focused on A. longa due to its wide range of applications [18,36,37]. Several countries have documented the beneﬁts of utilizing this herb to cure and
control cancer, including Morocco [38] and Mexico
[27]. The study clearly shows that the presence of
saponins and ﬂavonoids in A. longa extract produces
dose-dependent cell death in a Burkitt's lymphoma
cell line (BL41). Burkitt's lymphoma experiences an
apoptotic process after being exposed to the plant
extract, which results in the loss of mitochondrial
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membrane potential and the activation of caspases-9
and -3 [39]. Previous researchers have found that
increasing serum creatine, urea, and even uric acid
levels with 1 g of A. longa could be harmful to kidney
function in breast cancer patients [40e42].

6. Toxicity
Aristolochia is exceedingly lethal. It contains aristolochic acid, which is carcinogenic and detrimental
to the kidneys. According to Gadouche et al. [43] and
Grollman et al. [44], the toxicity of A. longa is mostly
due to aristolochic acid, a poisonous chemical found
in virtually all species of Aristolochia that is
responsible for nephropathic syndromes. Furthermore, lysis of red blood cells was observed when
treated with the plant extract, indicating severe
toxicity. Saponins, which are secondary metabolites,
were identiﬁed in aqueous extracts of the plant, and
this may lead to the stimulation of hemolysis as well
as apoptotic erythrocyte death. Consumption of dietary polyphenols may result in undesirable effects
such as hemolytic anemia. Therefore, it is recommended that before using these polyphenols for
therapy, they be evaluated for safety [45].
The use of Aristolochia can cause renal damage,
necessitating dialysis or a kidney transplant. It also

signiﬁcantly raises the risk of bladder cancer and other
urinary tract malignancies. Cherif and his colleagues
investigated the toxicological proﬁle of A. longa. They
reported that A. longa (2.5 g/kg/day b. wt) treatment for
28 days had an effect on the biochemical indices of
Wistar rats [46]. An in-vivo study reported that oral
administration of the root aqueous extracts for 21 days
at different doses shows toxic effects on both the liver
and kidney functions in a dose-dependent trend [47].
Many studies have found that consuming A. longa
(2.5 g/kg/day) produces histological damage to the
hepatic and renal tissues [47,48].

7. Application of A. longa
Aristolochia species have been employed in
traditional therapies for obstetrics and the treatment
of intestinal affections, cutaneous disorders, wound
healing, heart palpitation or snakebite, festering
wounds, and tumors [27,49].

8. Limitations/drawbacks in the usage of A.
longa
Despite its importance in treating or healing
diseased processes, this herb includes aristolochic
acid (AA) [25,50], a toxin responsible for the

Fig. 3. Schematic representation of pharmacological properties of A. longa L.
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development of clinical syndromes such as nephropathy [51]. The major limitation of this plant is
its toxicity. Being a potent nephrotoxic, aristolochic
acid (AA), one of the major constituents of the plant,
is still being extensively investigated for its pharmacological properties [47]. did a toxicological study
on A. longa extract and concluded that A. longa could
be toxic since it caused renal, liver, and intestinal
toxicity. However, even at large dosages, the herb
did not create substantial harmful effects at the start
of the experiment, implying that, in addition to the
AA, there may be other key constituents in A. longa
dominating the intensity of toxicity, action speed,
and possessing immunomodulatory properties able
to involve immune responses in induced lesions.
Further studies should be conducted to determine
the effects of this plant on pregnant animals and
their fetuses over longer study periods to complete
the toxicity proﬁle of this plant.

9. Conclusions
The ethnobotanical study concluded that this
plant was widely used by the local population of
Western Algeria to treat many illnesses and disorders, particularly the roots and leaves. However, as
demonstrated in Fig. 3, the plant has many properties, including anticancer, antidiabetic, antifungal/
antimicrobial, antitumor, antioxidant etc. The potency of this plant (A. longa) is due to the presence of
bioactive components such as b-carotenes, limonenes, tannins, ﬂavonoids, and palmitic acids or
saponins. However, from the critical evaluation of
this plant, it could very well be very toxic to the
body system (liver, kidneys, intestines, etc.)
depending on the consumption rate. It will be
important to learn more about its effects on pregnant women and the developing fetus in the future.
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